In a world-first, ten paediatric hospitals across five Australian states have partnered with the National Allergy Centre of Excellence (NACE), hosted at Melbourne’s Murdoch Children’s Research Institute (MCRI), to be the first globally to introduce a nation-wide peanut oral immunotherapy (OIT) program into mainstream care in Australia. Lester Kiewit speaks to Professor Kirsten Perrett, Head of the ADAPT OIT Program and Director of the National Allergy Centre of Excellence in Australia.